albuterol has been researched along with Lymphopenia in 3 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Lymphopenia: Reduction in the number of lymphocytes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Airway inflammation in chronic obstructive pulmonary disease (COPD) is characterised by infiltration of CD8+ T cells and CD68+ macrophages and an increased number of neutrophils, whereas few studies have described the presence of eosinophils." | 2.73 | Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial. ( Bourbeau, J; Christodoulopoulos, P; Hamid, Q; Maltais, F; Olivenstein, R; Yamauchi, Y, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fedor, ME | 1 |
| Rubinstein, A | 1 |
| Bourbeau, J | 1 |
| Christodoulopoulos, P | 1 |
| Maltais, F | 1 |
| Yamauchi, Y | 1 |
| Olivenstein, R | 1 |
| Hamid, Q | 1 |
| Spring, J | 1 |
| Johnston, SR | 1 |
| Seale, J | 1 |
| Ind, PW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Feasibility and Safety of Immunoglobulin (Ig) Prophylactic Treatment in COPD Patients With Frequent Exacerbations: A Pilot Study[NCT02690038] | Phase 2 | 48 participants (Actual) | Interventional | 2016-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for albuterol and Lymphopenia
| Article | Year |
|---|---|
Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial.
Topics: Administration, Inhalation; Aged; Albuterol; Androstadienes; Bronchitis; Bronchodilator Agents; CD8- | 2007 |
Failure of salmeterol to inhibit circulating white cell responses and bronchoconstriction induced by platelet activating factor.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Bronchoconstriction; Double-Blind Method; Female; Humans | 1992 |
1 other study available for albuterol and Lymphopenia
| Article | Year |
|---|---|
Effects of long-term low-dose corticosteroid therapy on humoral immunity.
Topics: Acetates; Agammaglobulinemia; Albuterol; Anti-Asthmatic Agents; Antibodies, Bacterial; Antibody Form | 2006 |